An international team of researchers conducted a clinical trial on 493 adults whose major depression hadn't previously ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Those on the extreme end of the depression spectrum face symptoms that impact their daily activities too and not just their ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

The study observed that self-reflection and positive approach can help in improving the symptoms of depression ...

Neumora Therapeutics stock collapsed Thursday after its experimental depression treatment failed in the first of three ...

Providers, patients and even some federal judges say progress-based insurance denials harm patients at key moments of mental ...

The clinical-stage biopharmaceutical company said the Phase 3 study didn't demonstrate a statistically significant improvement on the primary endpoint of change from baseline in a scale that measures ...

Professor Raz Yirmiya’s research connects stress, inflammation, and depression, uncovering potential new treatments for ...

A thin wire connects the device to the left vagus nerve in the neck – a major nerve that serves as a communication highway ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

At Sunrise Psychiatry Inc, Dr. Sonni Elliott & her team are using TMS (transcranial magnetic stimulation), a FDA-approved treatment, to help treat depression and anxiety.